GlaxoSmithKline will report its financial results for 2012 on Wednesday. The firm which carried out the acquisition of Human Genome Sciences for $3.6 billion last year saw its stock price decline from…
LONDON, Nov 1 (Reuters) - GlaxoSmithKline Plc : * Temporary increase in conversion rate for human genome sciences 3 percent…
The new masters of Human Genome Sciences are continuing to chop away employees. Just weeks after letting state officials in Maryland know that it was laying off 114 workers, or roughly 10% of its work…
DRI Capital acquired Biogen Idec's royalty rights to Benlysta, a lupus treatment owned by Human Genome Sciences and its acqui -More- …
